Sequential 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) scan findings in patients with extrapulmonary tuberculosis during the course of treatment—a prospective observational study
- 2 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 47 (13), 3118-3129
- https://doi.org/10.1007/s00259-020-04888-7
Abstract
Background Initial studies of tuberculosis (TB) in macaques and humans using 18F-FDG positron emission tomography (PET) imaging as a research tool suggest its usefulness in localising disease sites and as a clinical biomarker. Sequential serial scans in patients with extrapulmonary TB (EPTB) could inform on the value of PET-CT for monitoring response to treatment and defining cure. Patients and methods HIV-negative adults with EPTB from eight sites across six countries had three 18F-FDG PET/CT scans: (i) within 2 weeks of enrolment, (ii) at 2 months into TB treatment and (iii) at end of ATT treatment. Scanning was performed according to the EANM guidelines. 18F-FDG PET/CT scans were performed 60 ± 10 min after intravenous injection of 2.5–5.0 MBq/kg of 18F-FDG. Findings One hundred and forty-seven patients with EPTB underwent 3 sequential scans. A progressive reduction over time of both the number of active sites and the uptake level (SUVmax) at these sites was seen. At the end of WHO recommended treatment, 53/147 (36.0%) patients had negative PET/CT scans, and 94/147 (63.9%) patients remained PET/CT positive, of which 12 patients had developed MDR TB. One died of brain tuberculoma. Interpretation Current 18F-FDG PET/CT imaging technology cannot be used clinically as a biomarker of treatment response, cure or for decision-making on when to stop EPTB treatment. PET/CT remains a research tool for TB and further development of PET/CT is required using new Mycobacterium tuberculosis-specific radiopharmaceuticals targeting high-density surface epitopes, gene targets or metabolic pathways.Keywords
Funding Information
- International Atomic Energy Agency (CRPE15021)
This publication has 27 references indexed in Scilit:
- Extrapulmonary tuberculosis: are statistical reports accurate?Therapeutic Advances in Infectious Disease, 2014
- Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killingNature Medicine, 2013
- Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy RegimensAntimicrobial Agents and Chemotherapy, 2013
- 18-fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case seriesBMC Pulmonary Medicine, 2013
- Infection Dynamics and Response to Chemotherapy in a Rabbit Model of Tuberculosis using [ 18 F]2-Fluoro-Deoxy- d -Glucose Positron Emission Tomography and Computed TomographyAntimicrobial Agents and Chemotherapy, 2012
- Magnetic Resonance evaluation of tubercular lesion in spineInternational Orthopaedics, 2011
- Use of 18F-FDG PET to Predict Response to First-Line Tuberculostatics in HIV-Associated TuberculosisJournal of Nuclear Medicine, 2011
- Comparison of pulmonary and extrapulmonary tuberculosis in Nepal- a hospital-based retrospective studyBMC Infectious Diseases, 2008
- Extrapulmonary tuberculosis: clinical and epidemiologic spectrum of 636 casesArchives of Medical Research, 2004
- 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammationSeminars in Nuclear Medicine, 2002